Form 8-K CATALYST PHARMACEUTICALS For: Dec 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
21,470$
1,66%
Echtzeit-Aktienkurs Catalyst Pharmaceuticals
Bid:
Ask:
Nachrichten zur Catalyst Pharmaceuticals Aktie
Catalyst Pharmaceuticals Shares Rise 12%, Hit All-Time High
Catalyst Pharmaceuticals Shares Rise 12%, Hit All-Time High...…
Catalyst Pharma gains U.S. rights to Eisai epilepsy drug Fycompa
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
Acquisition Expands The Companys Commercial Portfolio With An Established U.S. Marketed Product...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Catalyst Pharmaceuticals im Wert von 99.718$
Ingenito, Gary - Vorstand - Tag der Transaktion: 2022-12-06...…
Insiderhandel: President and CEO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 5.467.700$
Mcenany, Patrick J. - Vorstand - Tag der Transaktion: 2022-11-18...…
Insiderhandel: President and CEO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 2.299.800$
Mcenany, Patrick J. - Vorstand - Tag der Transaktion: 2022-11-21...…
Catalyst Pharma hits 52-week high amid acquisition hopes
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
Catalyst (CPRX) delivered earnings and revenue surprises of 5.26% and 6.40%, respectively, for the quarter ended September 2022. Do the…
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
Conference Call and Webcast to be held on November 10, 2022, at 8:30 AM ET Conference Call and Webcast to…
Zacks Industry Outlook Highlights Jazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie Pharmaceuticals, Larimar Therapeutics and Fusion Therapeutics
Jazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie Pharmaceuticals, Larimar Therapeutics and Fusion Therapeutics have been highlighted in this Industry Outlook article....…
Is Catalyst Pharmaceuticals (CPRX) Stock Outpacing Its Medical Peers This Year?
Here is how Catalyst Pharmaceutical (CPRX) and IMARA Inc. (IMRA) have performed compared to their sector so far this year....…